Abstract
Esthesioneuroblastoma is a sinonasal tumor with distinct clinicopathologic features, multiple facets, and a spectrum of behavior. Characterization of this disease is challenging, and clinically, several staging systems have been used with no consensus on a single scheme. Recently, the Hyams histological grading system has emerged as a promising prognostication tool that offers an added value to stage. This review addresses prognosis and biology in esthesioneuroblastoma. More specifically, we sought to present a critical appraisal on the value of each of these stratification systems, stage vs. grade, in identifying risk groups and guiding management.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1-5 |
| Number of pages | 5 |
| Journal | Current oncology reports |
| Volume | 17 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2015 |
Keywords
- Esthesioneuroblastoma
- Grade
- Hyams
- Kadish
- Morita
- Olfactory Neuroblastoma
- Outcome
- Prognosis
- Stage
ASJC Scopus subject areas
- Oncology